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Abstract
Background: Whole body vibration (WBV) training is a regime of training on a vibration 
platform that provides oscillatory movement to the body. Vibration training may be a potentially 
useful therapeutic strategy to control diabetes and its complications. This study aimed to evaluate 
the effect of WBV on glycemic indices and peripheral blood flow in type II diabetic patients.
Methods: A parallel group clinical trial was conducted with 1:1 allocation ratio at Khon 
Kaen University between February and May 2010. The study included diabetic patients receiving 
diet or oral medication control over the previous year and excluded patients with serious medical 
and musculoskeletal disorders. Forty type II diabetic patients [14 males, 26 females, 63.2 (7.7) y, 
mean (SD)] were randomised into two groups (WBV and control) by computer software using a 
block of four design. The WBV group was given two sets of six one-minute vibration squats, three 
times per week for twelve weeks. The control group maintained their normal physical activity 
levels. The primary outcome was the patients glycemic indices. 
Results: We found no significant difference in glycosylated haemoglobin (HbA1c), fasting 
blood sugar, insulin level and insulin sensitivity between WBV and control groups. Compared to 
the control group, WBV training resulted in a substantial reduction in resting diastolic blood 
pressure -7.1 mmHg (95% CI: -10.9, -3.3, P = 0.001) and peak systolic velocity -7.3 cm.sec-1 (95% CI: 
-14.7, -0.03, P = 0.049), but made little difference to resting heart rate, systolic blood pressure, end 
diastolic velocity, and popliteal artery diameter.
Conclusion: Whole body vibration improved resting diastolic blood pressure and peak 
systolic velocity, however, any beneficial effect of WBV on glycemic indices remains unclear. 
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disease (1). Currently, management of diabetes 
consists of medication, diet control, exercise and 
lifestyle modification.  
Whole body vibration (WBV) is an 
innovative exercise training regime that utilises 
electric motors to provide vibration movement to 
Introduction
Type II diabetes or adult-onset diabetes 
is the most common type of diabetes and 
leads to complications including retinopathy, 
nephropathy, neuropathy and cardiovascular 
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an individual standing on a platform. Vibration 
training has been suggested to be a useful 
alternative or supplement to current exercise 
prescriptions for diabetic patients (2). It is 
thought that vibration training stimulates muscle 
contraction, increases peripheral blood flow, and 
energy consumption (3, 4), all of which may help 
with diabetes and its complications. 
Whole body vibration stimulates muscle 
contraction by activating muscle spindles, 
thereby enhancing stretch-reflex activation 
(5). Normal regular WBV training is suggested 
to generate muscle adaptation similar to 
normal resistance exercise training (6). It is 
well accepted that regular physical exercise 
increases glucose uptake in exercising muscle, 
resulting in enhanced insulin sensitivity in 
diabetics (7). For that reason, regular WBV 
training may help diabetic patients to control 
glucose metabolism by reducing fasting blood 
sugar (FBS), glycosylated hemoglobin (HbA1c; a 
marker for evaluating average blood sugar levels 
over the previous 3 months), fasting insulin and 
increasing insulin sensitivity. 
Previous research indicates controversial 
effects of WBV on glucose metabolism in 
diabetes patients. Baum et al. (2) revealed 
FBS and HbA1c levels in type II diabetics were 
reduced by approximately 6.3% and 0.3% 
respectively after 12 weeks of WBV using a 
horizontal swinging platform (30–35 Hz, 2 
mm amplitude, 8 bouts of 30 seconds, 3 days a 
week). More recently, del Pozo-Cruz et al. (9) 
reported 12 weeks of WBV training (12–16 Hz, 4 
mm, 3 days a week) significantly improved levels 
of FBS and HbA1c. However, in contrast to the 
beneficial effects reported by Baum et al. (2) and 
del Pozo-Cruz et al. (9), Behboudi et al. (8) found 
that FBS and HbA1c levels were not significantly 
improved after 8 weeks of WBV training (30 
Hz, 2 mm, 3 days a week). It therefore seems 
that the effect of WBV on glucose metabolism in 
diabetics remains unclear and requires further 
investigation. 
As a consequence of a disrupted glucose 
metabolism, diabetics also suffer from peripheral 
vascular disorders. One of the purported benefits 
of whole body vibration training is improved 
vascular blood flow. However, the beneficial 
change in local blood flow with vibration still 
remains controversial. Kerschan-Schindl et al. 
(10) showed mean blood flow velocity in the 
popliteal artery of healthy adults increased 
100% after 9 minutes of vibration training (26 
Hz, 3 mm,). In addition, Lohman et al. (11) 
revealed skin blood flow of the lower leg was 
increased by approximately 147% after 3 bouts 
of 60 seconds of vibration training (30 Hz, 5-6 
mm). Lythgo et al. (12) suggested the increased 
leg blood flow accompanying WBV in healthy 
volunteers was related to high frequency and 
high amplitude of vibration. However, using high 
frequency, Button et al. (13) and Hazell et al. (14) 
reported no significant difference in local blood 
flow in healthy participants between vibration 
and control groups. In diabetic patients, and 
in contrast to Lythgo et al. (12) findings on 
healthy subjects, Johnson et al. (15) showed 
low frequency (26 Hz) and low amplitude (2 
mm) vibration increased blood flow (to the skin 
area in the feet). Similarly, Sañudo et al. (16) 
revealed significant improvement of femoral 
artery blood flow after 12 weeks of WBV training 
in diabetic patients (12–16 Hz, 4 mm, 3 days a 
week). Whether WBV can have a positive effect 
on local blood flow of diabetic patients remains 
controversial and requires further investigation.
The aim of this study was to evaluate the 
effect of WBV as an additional therapy to diet or 
oral medication in our clinical setting on FBS, 
HbA1c, fasting insulin levels, insulin sensitivity 
and peripheral vascular blood flow on a cohort of 
Type II diabetic patients.
Materials and Methods
Study Design 
A randomised control trial was conducted 
in parallel groups with an allocation ratio 1:1 
at Srinagarind Hospital, KhonKaen University 
between February and May 2010. 
Study Population
The type II diabetic patients who were 
diagnosed by a registered medical physician and 
came to the primary care unit of Srinagarind 
Hospital Khon Kaen University were recruited in 
this study. The patients were recruited through 
poster advertisement and primary doctors 
who took care of the patients. Forty patients 
who met the following criteria were tested pre- 
(baseline) and 12 weeks after (post) intervention. 
Inclusion criteria for type II diabetics included, 
patients receiving diet control programs or 
oral medication for diabetes over the last year. 
Exclusion criteria included (i) having any serious 
medical diseases (e.g. diabetic retinopathy, 
myocardial infarction, uncontrolled hypertension 
or renal failure), (ii) having previous hip, knee 
or shoulder operations or, (iii) any uncontrolled 
back, ankle, knee and hip pain.  
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Figure 1. Consort diagram
Whole Body Vibration Program
The WBV group was trained on a vertical 
vibration machine (Fitvibe Excel; Belkin, 
Belgium) for two sets of 6 one-minute vibration 
squats interspersed with 20 second rest periods, 
3 times per week for 12 weeks (total exercise time 
of 36 minutes per week). The six static positions 
consisted of, (a) a deep squat position (knee 
angle 90o), (b) high squat position (knee angle 
125o), (c) high squat position (with raised heels), 
(d) slight knee flexion 1 (holding hand straps 
with shoulder flexion), (e) slight knee flexion 2 
(holding hand straps with shoulder abduction) 
and (f) slight knee flexion 3 (holding hand straps 
with elbow flexion) (Figure 2). The training load 
increased progressively from an initial vibration 
frequency of 30 Hz and a platform amplitude 
shift of 2 mm (1.43 g in peak acceleration) in 
week 1, to 40 Hz, and 4 mm (7.34 g in peak 
acceleration) in week 5, which was maintained 
until the end of the study (week 12). Adverse 
effects were recorded throughout the training 
program. The control group was told to maintain 
their normal physical activity levels for 12 weeks. 
Assessment
Resting Physiological Measures
All physiological measures were taken at the 
clinic at the same time of day with participants 
wearing light clothing and no shoes. Weight and 
height were measured using a beam balance scale 
with an attached stadiometer (Detecto scales, 
Randomisation and Allocation 
Concealment
The participants were randomly allocated 
into the WBV or the control group. The 
randomised allocation was performed by the 
office of Rehabilitation Medicine Department 
without any influence of the investigators. The 
allocation sequence was generated by computer 
software using a block size of four, and was 
concealed by sequentially numbered, sealed and 
opaque envelopes. 
Blinding
The patients could not be blinded because 
this study compared WBV training and non-
training. The period of training was 12 weeks 
which made it difficult to conceal the patient 
groups as all patients lived in the same village. 
However, the investigators who measured the 
physiological outcomes such as weight, height, 
heart rate and blood pressure and completed 
blood test analyses at baseline and at the end of 
study were blinded to the allocation treatment. 
In addition, the radiologist who performed the 
ultrasound Doppler before and after training was 
also blinded to patient group information.  
Sample Size Calculation
The sample size estimation which compared 
means of two independent groups was calculated 
based on a type I error (α) = 0.05, type II error 
(β) = 0.2, mean difference (µ1 - µ2) = 5, variance 
= 25 from Baum et al. study (2). The number of 
participants required using this calculation was 
16 per group. After considering a normal rate of 
drop outs (20 %), the total sample size per group 
was 20 per group.
Study Protocol
Forty diabetic patients, 20 for WBV and 
20 for control group, were included in this 
study. Three people in the WBV group and 
one in the control group withdrew because of 
time constraints (Figure 1). Of the 17 included 
in the WBV group, 16 completed 100% of the 
vibration training and one 70% of the training. 
All participants were instructed to maintain 
their normal diet, normal level of physical 
activity and prescribed medications throughout 
the experiment. The protocol of this study was 
approved by the Khon Kaen University Ethics 
Committee for Human Research (approval 
number HE521307) and Human Ethics 
Committee of Lincoln University (approval 
number 2009-52).
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minute rest, was performed by an experienced 
radiologist. Each artery segment was examined 
with a 10-MHz linear array transducer with a 
Toshiba Xario XG scanner (Toshiba Medical 
Systems, Tokyo, Japan) at a room temperature 
of 25 oC. The color-flow mode was used to 
identify the vessel and to position the sample 
volume. The diameter of the arteries was 
obtained by longitudinal imaging, placing the 
tracker ball-guided calipers across the intimal-
luminal interphases of the near and far walls. 
Measurements were repeated three times, then 
averaged. A computer spectral analysis of the 
Doppler signals was completed to obtain profiles 
of the velocity waveforms (peak systolic velocity 
(PSV), end diastolic velocity (EDV)). This is 
possible by allowing the sample volume gate's 
to be adjusted to encompass the entire lumen 
of the artery and the angle of insonation being 
maintained at 60°. Doppler spectral waveforms 
containing aliasing, (noise due to venous flow or 
wall motion) were discarded. The mean of three 
different sets of flow estimations was obtained 
per patient both pre and post intervention.
Statistical Analysis
The data analysis was conducted as a 
per protocol analysis that did not include any 
participants that dropped out of the study. 
The statistical analysis was performed by SPSS 
version 19. The normal distribution of the data 
was evaluated by Kolmogorov–Smirnov test. 
New York, USA). Weight was measured by taking 
two measurements to the nearest 0.1 kg. If the 
measures differed by more than 0.5 kg, a third 
measurement was taken and the mean of the two 
closest measurements recorded. Height (to the 
nearest 0.1 cm) was similarly determined. Blood 
pressure of the upper right arm was measured 
in sitting position using an automatic blood 
pressure monitor (Terumo ES H55, Terumo Co., 
Japan) after 15 minutes of rest. 
Blood Samples and Insulin Sensitivity
All blood samples were taken by 
venipuncture of the antecubital vein in the 
morning after an overnight fast. The samples 
were analysed by experienced laboratory 
technicians using an automated machine 
(Cobas® 6000 analyser; Roche Diagnostics 
Corp., Indianapolis, IN, USA) for FBS, HbA1c, 
and an Automatic Gamma Counter (Wallac 
1470 Wizard, Perkin Elmer Inc., Boston, MA, 
USA) for fasting insulin level. In this study, 
the quantitative insulin sensitivity check index 
(QUICKI) was calculated from the inverse of 
the sum of the logarithm of fasting insulin and 
fasting glucose [1 / (log (fasting insulin µIU/mL) 
+ log (fasting glucose mg/dL)] (17).
Ultrasound Doppler
Duplex ultrasound (US) scanning of the 
right popliteal artery at the mid popliteal fossa 
with the patient in a prone position, after a 15 
Figure 2. Positions of whole body vibration training
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substantially improved in both groups. Insulin 
levels significantly decreased in control group, 
but no change of insulin levels were observed 
in WBV group. However, the control group had 
significantly increased HbA1c by 0.4% (95% 
CI: 0.1, 0.7, P = 0.009) from baseline, while the 
participants who underwent vibration training 
had little change in Hb1Ac (-0.09%, 95%CI: 
-1.0, 0.8, p = 0.819). There was no statistically 
significant difference in FBS, HbA1c, insulin level 
and QUICKI between WBV and control group 
over the course of the study (Table 2).
The WBV group decreased resting diastolic 
blood pressure, whereas no substantial change 
was found in the control group during the study 
resulting in a substantial difference between 
groups over the study by -7.1 mmHg (95% CI: 
-10.9, -3.3, P = 0.001). We found very little 
difference in resting heart rate or resting systolic 
blood pressure within or between groups (Table 
3). Ultrasound Doppler showed a decrease 
in peak systolic velocity by -7.3 cm.sec-1 (95% 
CI: -14.7, -0.03, P = 0.049) in the WBV group 
compared to control group. The end diastolic 
velocity in the WBV group decreased from 
baseline by -3.1 cm.sec-1 (95% CI: -5.4, -0.8, P 
= 0.011), but there was no significant difference 
compared to control group. The diameter of 
the right popliteal artery in both groups did not 
differ throughout the study (Table 3).
Discussion
The main novel findings of this study are 
that 12 weeks of WBV training substantially 
The descriptive data is presented as mean, 
standard deviation and 95% confidence interval. 
The baseline characteristics of treatment and 
control groups were analysed by an independent 
sample t-test for continuous data and Chi-
square test for nominal data. The analysis of 
pre- and post-intervention variables including 
body weight, body mass index (BMI), FBS, 
HbA1c, insulin level, insulin sensitivity, heart 
rate, systolic and diastolic blood pressure, peak 
systolic velocity, end diastolic velocity and vessel 
diameter was analysed using a paired sample 
t-test. Subsequently an analysis of covariance 
(ANCOVA), with adjusted mean change from 
baseline, was used to investigate differences 
between groups. Statistical significance was 
accepted at P-value < 0.05. 
Results
Thirty-six participants (13 males and 23 
females, age 63.2 (7.7) years, BMI 26.1 (3.6) 
kg.m-2, FBS 142.8 (43.9) mg.dl-1, duration of 
diabetes 7.8 (5.7) years, mean (SD)), completed 
the two testing protocols (baseline, post 
intervention). The per protocol analysis revealed 
there was no substantial difference between 
the WBV and control groups in age, duration 
of diabetes diagnosis, body weight, BMI, FBS, 
HbA1c (Table 1). No adverse effects of WBV were 
reported throughout the study.  
After 12-weeks training, we found very little 
difference in body weight and BMI from baseline 
and between groups. Compared to baseline, 
fasting blood sugar and insulin sensitivity was 
Table 1. Characteristics of WBV and control groups (mean (SD))
WBV
(n = 17)
CON
(n = 19) P-value
Age  (year) 60.9 (11.2) 63.9 (4.9) 0.318
Sex M  7  / F 10 M 6 / F 13
Duration (year) of diabetes diagnosis 6.9 (5.4) 8.5 (5.9) 0.422
Body weight (kg) 61.4 (7.8) 63.6 (12.3) 0.527
BMI (kg.m-2) 25.7 (2.4) 26.7 (4.2) 0.406
FBS (mg.dl-1) 148.7 (38.0) 130.1 (25.5) 0.100
HbA1c (%) 8.5 (1.9) 7.8 (1.4) 0.208
Insulin (µIU.ml-1) 20.8 (6.7) 22.6 (10.6) 0.539
QUICKI 0.289 (0.014) 0.294 (0.019) 0.471
BMI, body mass index; FBS, fasting blood sugar; HbA1c, glycosylated hemoglobin; QUICKI, the quantitative insulin 
sensitivity check index; CON, control; WBV, whole body vibration
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uptake of muscle cells is probably similar to 
physical exercise. These mechanisms include 
enhanced glucose transporter protein GLUT4 via 
activation of post-receptor insulin signalling and 
AMPK (AMP-activated protein kinase), increased 
cytoplasmic calcium, enhanced autocrine or 
paracrine (nitric oxide) response, and increased 
glycogen synthase and phosphorylase activities 
reduced diastolic blood pressure and peak 
systolic velocity. However, the beneficial effects 
of WBV on glycaemic indices remained unclear.
It is thought that WBV stimulates the 
stretch reflex by activating muscle spindles 
to enhance muscle contraction (5), leading to 
increase glucose utilisation. The physiological 
mechanisms behind WBV's effect on glucose 
Table 2. Pre, post intervention and adjusted mean difference in BW, BMI, FBS, HbA1c and QUICKI of 
WBV and control groups (mean (SD))
WBV
P-value
Control
P-value
Adjusted mean 
difference
(95%CI)
P-value
Pre Post Pre Post
BW (kg) 61.4 
(7.8)
61.7 
(7.3)
0.681 63.6 
(12.3)
63.9 
(12.3)
0.449 -0.2 (-1.7, 1.3) 0.801
BMI(kg.m-2) 25.7 
(2.4)
25.8 
(2.9)
0.584 26.6 
(4.2)
26.7 
(4.0)
0.459 -0.1 (-0.8, 0.6) 0.787
FBS (mg.dl-1) 148.6 
(38.0)
119.8 
(22.7)
0.003* 130.1 
(25.5)
114.9 
(42.5)
0.008* -10.8 (-25.0, 3.3) 0.129
HbA1c (%) 8.5 
(1.9)
8.4 
(1.3)
0.819 7.8 
(1.4)
8.1 
(1.4)
0.009* -0.2 (-0.8, 0.4) 0.534
Insulin (µIU.ml-1) 20.8 
(6.7)
17.8 
(6.3)
0.193 22.6 
(10.6)
18.3 
(8.0)
0.022* -0.01 (-4.2, 4.2) 0.996
QUICKI 0.29 
(0.0)
0.30 
(0.0)
0.016* 0.29 
(0.0)
0.31 
(0.0)
0.004* -0.002 
(-0.016,0.011)
0.710
BW, body weight; BMI, body mass index; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBS, fasting 
blood sugar; HbA1c, glycosylated hemoglobin; QUICKI, the quantitative insulin sensitivity check index; WBV, whole body vibration; 
* significant differences between pre and post-test (P < 0.05).
Table 3. Pre, post intervention and adjusted mean difference in HR, SBP, DBP, PSV, EDV, vessel 
diameter of WBV and control groups (mean (SD))
WBV
P-value
Control
P-value
Adjusted mean 
difference
(95%CI)
P-value
Pre Post Pre Post
HR (beat.min-1) 78.5 
(14.0)
79.3 
(13.0)
0.680 77.4 
(11.8)
74.6 
(10.0)
0.238 4.0 (-1.4, 9.5) 0.142
SBP (mmHg) 133.6 
(16.7)
128.0 
(13.9)
0.145 133.8 
(12.2)
129.5 
(11.8)
0.073 -1.4 (-8.7, 5.9) 0.698
DBP (mmHg) 74.6 
(15.6)
66.1 
(5.9)
0.009* 71.6 
(12.2)
71.7 
(10.7)
0.951 -7.1 (-10.9,-3.3) 0.001**
PSV (cm.sec-1) 55.6 
(14.6)
51.6 
(11.3)
0.106 63.6 
(19.4)
63.8 
(17.2)
0.880 -7.3(-14.7, -0.03) 0.049**
EDV (cm.sec-1) 4.4 
(5.4)
1.2 
(4.8)
0.011* 5.3 
(6.8)
3.5 
(4.2)
0.353 -2.0 (-4.9,0.8) 0.158
Diameter (mm) 6.1 
(0.9)
6.2 
(0.5)
0.738 6.2 
(0.8)
6.2 
(0.8)
0.883 0.005(-0.3,0.4) 0.976
WBV, whole body vibration; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; PSV, peak systolic velocity; 
EDV, end diastolic velocity; Diameter, popliteal artery diameter; * significant differences between pre and post-test (P < 0.05); 
** significant differences between WBV and control group (P < 0.05).
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had little effect on resting heart rate (14). An 
interesting finding from the current study was 
that regular WBV training substantially reduced 
peak systolic velocity of the right popliteal artery. 
Whole body vibration may reduce vascular 
stenosis or resistance, which is positively 
correlated to peak systolic velocity (22). The 
proposed underlying mechanism suggests that 
acute vibration exposure may reduce peripheral 
vascular resistance by inhibiting vasoconstrictor 
substance release (endothelin) from smooth 
muscles (23). As with the adaptation process 
in exercise training, regular WBV training may 
alter peripheral blood vessels by increasing the 
size of the capillary bed of the skeletal muscle 
(24), or by increasing arteriole vasodilatation 
by releasing endothelial nitric oxide and 
prostaglandins (25).
We did not observe any adverse effects of 
WBV on type II diabetic patients such as pain, 
abnormal sensation, injury or hypoglycaemia. 
However, adverse effects related to diabetic 
complications such as retinopathy and 
nephropathy can occur with exercise. Vigorous 
exercise may trigger vitreous haemorrhage 
or retinal detachment in severe diabetic 
retinopathy, and may increase urinary protein 
excretion (26). Therefore, WBV with high loads 
and prolonged exposure times may put such 
patients at risk of these complications. This study 
did not perform retinal examination or monitor 
renal function, however, we suggest future 
research into the area of WBV and diabetes 
should consider such monitoring.  
A limitation of this study is that the 
participants were diabetic patients who received 
diet control programs or oral medication and 
were trained at a primary care unit that allowed 
the participants to maintain their normal 
daily lifestyle; therefore, the results of this 
study cannot be applied to all diabetic patients 
in general. In addition, the variation in the 
glycemic measures was higher than expected 
which resulted in a reduction in the statistical 
power of the study for these glycemic measures. 
We would recommend future studies to stratify 
diabetic patients based on the degree of severity 
of diabetes using baseline HbA1c or duration of 
disease measures. 
Conclusion
Our study revealed WBV training in type 
II diabetic patients had no significant beneficial 
effects on the control of FBS, HbA1c, insulin 
(18). Exercise also increases muscle glucose 
delivery and utilisation by increasing muscle 
blood flow, muscle capillary density and muscle 
mass (19, 20). In diabetic patients, WBV may 
help diabetic control by improving beta cell 
function and insulin resistance or enhanced 
responsiveness of muscle glucose uptake, similar 
to physical exercise (7, 21). The participants in 
both groups had lower FBS and insulin levels and 
higher insulin sensitivity in the post compared 
to the pre-test. These results may be explained 
by the fact that all participants received 
conventional treatment for their diabetes during 
the study including diet and medication control. 
While there was some within group changes as 
a result of the study, the between group results 
suggest that compared to controls using WBV 
training has little beneficial effect on indicators 
of glycaemic control (Table 2). Our results 
corroborate previous work by Baum et al. (2) 
and Behboudi et al. (8) who found that FBS and 
HbA1c were not significantly improved in the 
WBV group compared to control groups. 
Perhaps the workload of traditional WBV 
training is not sufficiently intense or long enough 
to provide substantial change. An increased 
duration of training (per session), regularity of 
training (per week) and intensity of WBV such 
as adding loads on the body or dynamic exercise 
training while completing WBV may provide 
better results than reported here. In contrast, del 
Pozo-Cruz et al. (9) recently revealed WBV had 
significant beneficial effects on FBS and HbA1c. 
The baseline HbA1c of our study (8.5% for 
intervention and 7.8% for control) is higher than 
del Pozo-Cruz et al. study (7.3% for intervention 
and 7.0% for control) and we suspect the 
severity of diabetes may affect resultant glycemic 
outcomes. Future research should investigate to 
what extent severity of diabetes has on glycemic 
outcomes in a training study. 
After 12-weeks of WBV training, both 
systolic and diastolic resting blood pressure in 
our subjects (substantial decrease in diastolic 
only) decreased compared to controls. It is 
suggested that WBV may dilate small blood 
vessels in muscles and thereby decrease 
peripheral vascular resistance (10). If this is the 
case, diastolic blood pressure, which is mainly 
determined by peripheral vascular resistance, 
would tend to decrease also. Since systolic 
blood pressure is mainly determined by cardiac 
output, changes in peripheral resistance would 
not be as obvious on systolic blood pressure. 
Similar to previous research, we found that WBV 
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